Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Sell
2
IMTX Quote, Financials, Valuation and Earnings
Last price:
$5.34
Seasonality move
:
-11.33%
Day range:
$5.28 - $5.49
52-week range:
$5.28 - $13.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.29x
P/B ratio:
1.52x
Volume:
1.1M
Avg. volume:
792.3K
1-year change:
-52.23%
Market cap:
$650.3M
Revenue:
$58.5M
EPS (TTM):
-$0.67
Analysts' Opinion
-
Consensus RatingImmatics NV has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.42, Immatics NV has an estimated upside of 206.85% from its current price of $5.35.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $13.00 representing -142.99% downside risk from its current price of $5.35.
Fair Value
-
According to the consensus of 5 analysts, Immatics NV has 206.85% upside to fair value with a price target of $16.42 per share.
IMTX vs. S&P 500
-
Over the past 5 trading days, Immatics NV has underperformed the S&P 500 by -19.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Immatics NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Immatics NV has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Immatics NV reported revenues of $55.6M.
Earnings Growth
-
Immatics NV has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Immatics NV reported earnings per share of -$0.12.
Enterprise value:
102.4M
EV / Invested capital:
--
Price / LTM sales:
4.29x
EV / EBIT:
--
EV / Revenue:
0.81x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.06x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-9.89%
Net Income Margin (TTM):
-47.93%
Return On Equity:
-16.88%
Return On Invested Capital:
-16.88%
Operating Margin:
1.02%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $167M | $79.8M | $125.8M | $6.5M | $55.6M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $18.7M | -$80.2M | -$72.5M | -$36.2M | $565.3K | |
| EBITDA | $50.7M | -$78.9M | -$39M | -$26.7M | $1M | |
| Diluted EPS | $0.66 | -$1.21 | -$0.67 | -$0.35 | -$0.12 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $313.3M | $208.9M | $316.8M | $407.5M | $572.7M | |
| Total Assets | $332.3M | $230.7M | $348.2M | $463M | $644.7M | |
| Current Liabilities | $89.5M | $124.2M | $122M | $128.2M | $144M | |
| Total Liabilities | $189.5M | $189.9M | $237.1M | $200.8M | $217.5M | |
| Total Equity | $142.8M | $40.8M | $111.1M | $262.2M | $427.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $102.4M | -$93.2M | -$23.5M | -$33.2M | -$38.6M | |
| Cash From Investing | -$122.6M | -$200M | -$50.2M | -$76.8M | $69.7M | |
| Cash From Financing | $17.7M | $205.2M | $189M | $54.3M | $3.2M | |
| Free Cash Flow | $96.5M | -$119.7M | -$49.6M | -$40.2M | -$42M | |
IMTX
Sector
Market Cap
$650.3M
$45.2M
Price % of 52-Week High
38.85%
46.55%
Dividend Yield
0%
0%
Shareholder Yield
-16.27%
-0.75%
1-Year Price Total Return
-52.23%
-33.5%
Beta (5-Year)
0.772
0.747
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.14
200-day SMA
Sell
Level
$10.33
Bollinger Bands (100)
Sell
Level
7.21 - 11.07
Chaikin Money Flow
Sell
Level
-39.7M
20-day SMA
Sell
Level
$6.69
Relative Strength Index (RSI14)
Sell
Level
21.22
ADX Line
Sell
Level
33.24
Williams %R
Buy
Level
-97.0954
50-day SMA
Sell
Level
$7.51
MACD (12, 26)
Sell
Level
-0.54
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
43.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.242)
Sell
CA Score
(Annual)
Level (-1.4637)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.8098)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Stock Forecast FAQ
In the current month, IMTX has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IMTX average analyst price target in the past 3 months is $16.42.
-
Where Will Immatics NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Immatics NV share price will rise to $16.42 per share over the next 12 months.
-
What Do Analysts Say About Immatics NV?
Analysts are divided on their view about Immatics NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Immatics NV is a Sell and believe this share price will drop from its current level to $13.00.
-
What Is Immatics NV's Price Target?
The price target for Immatics NV over the next 1-year time period is forecast to be $16.42 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IMTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Immatics NV is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IMTX?
You can purchase shares of Immatics NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Immatics NV shares.
-
What Is The Immatics NV Share Price Today?
Immatics NV was last trading at $5.34 per share. This represents the most recent stock quote for Immatics NV. Yesterday, Immatics NV closed at $5.35 per share.
-
How To Buy Immatics NV Stock Online?
In order to purchase Immatics NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
